To verify the receptor, S. aureus RN4220, a strain free of prophages (Kreiswirth et al., 1983), type I restriction mechanisms, and capsules (Wann et al., 1999), was utilized (Table 1). It is known that most genetic manipulation of S. aureus is confined to strain RN4220 because RN4220 is defective of type I restriction–modification (RM) system, whereas different lineages of S. aureus contain a unique pair of type I RM systems (Cooper et al., 2017). We obtained an RN4220ΔtagO:erm mutant, which lacks the peptidoglycan-anchored wall teichoic acid (WTA) (Swoboda et al., 2010), and its complemented strain carrying the pStagO plasmid. This plasmid was constructed by subcloning the tagO gene into an Escherichia coli–S. aureus shuttle expression vector, pND50 (Brückner, 1992). Afterward, 10 μL of 10-fold diluted phage PALS2 lysate (1010 to 103 PFUs/mL) was spotted from top–left to bottom–right on soft agar (TSB containing 0.4% agar), beginning with the highest titer, with the wild-type RN4220, the RN4220ΔtagO:erm mutant, and the tagO-complemented strain.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.